Navigation Links
Methadone Frequently Causes Menopausal Symptoms in Young Women
Date:5/7/2009

TARPON SPRINGS, Fla., May 7 /PRNewswire/ -- Methadone medication frequently depresses estradiol, progesterone and testosterone hormone levels to menopausal levels, even in women less than thirty years old. Hormonal suppression, caused by methadone, can cause depression, anxiety, fatigue, weight gain, bone loss, bladder pain, decreased pain tolerance, hot flashes, and increased risk for heart attack and stroke.

Dr. Rick Sponaugle, Medical Director of Florida Detox, observed, "Thirty of the last thirty female methadone patients, between 20 and 30 years old, who we detoxed from methadone arrived with estradiol, progesterone or testosterone hormone levels, in the post menopausal range."

A 1975 University of Pennsylvania study revealed severe hormonal suppression caused by narcotic pain medications. Despite this study, most methadone patients report physicians prescribing methadone failed to inform them of hormonal suppression risks caused by methadone. Physicians prescribing methadone, Vicodin, Oxycontin, Percocet, morphine and other opiate pain medications, seldom test or treat patients for hormonal deficiencies caused by these medications.

Although studies reveal methadone and other opiate pain medications do not benefit fibromyalgia patients, physicians frequently prescribe opiate pain medications to fibromyalgia patients. Fibromyalgia patients frequently become addicted to ineffective opiate pain medications, including methadone.

Many methadone patients are unable to persevere through painful methadone withdrawal symptoms, when methadone ceases providing pain relief. Methadone withdrawal symptoms frequently include anxiety, depression, insomnia, chills and sweats, diarrhea, nausea, muscle cramps and tremors and can include potentially deadly, heart rate and blood pressure increases. Depression and fatigue from methadone withdrawal frequently lasts a year, without effective addiction treatment.

Depression, fatigue, anxiety, and insomnia, caused by methadone often decrease rapidly, with bioidentical hormone replacement. Bone density increases exceeding ten percent annually, can be achieved, with hormone replacement, vitamin and mineral supplementation.

Florida Detox and Wellness Institute tests and treats estradiol, progesterone, testosterone, thyroid and dehydroepiandrosterone, DHEA, hormone deficiencies, caused by opiate pain medication.

Clinical research by Florida Detox and Wellness Institute proves many methadone dependent patients were self medicating pre-existing attention deficit disorders, anxiety and depression, with opiate pain pills. Many methadone patients need treatment for attention deficit disorders, insomnia, depression, anxiety and fatigue, in addition to hormone replacement. Skilled treatment with amino acids, vitamins, minerals, herbals and medications eliminates cravings for opiates.

Florida Detox has perfected scientifically advanced, compassionate, detoxification techniques for methadone, morphine, Vicodin, Oxycontin, Percocet, Norco, Fentanyl, Tramadol, heroin and other opiate drugs. Although many methadone detox programs will not detox patients who use more than 30 milligrams of methadone daily, Florida Detox has safely and successfully detoxed daily methadone doses as high as 2000 milligrams daily. Florida Detox has successfully detoxed over 100 methadone patients who were using over 1000 milligrams of methadone daily

Florida Detox also provides effective medical treatment for alcohol, Xanax, Klonopin, Ambien, Fioricet and Cocaine dependency. Florida Detox has treated over 5,000 patients for chemical dependency.

For more information see www.floridadetox.com or call Florida Detox at 1-888-775-2770.


'/>"/>
SOURCE Florida Detox and Wellness Institute
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer
2. St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse
3. Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented
4. PTC Announces Data Showing That PTC124 Causes Statistically Significant Improvements in Chloride Channel Function in Cystic Fibrosis Patients
5. Gene That Causes Childhood Cancer Neuroblastoma Is Found
6. Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of Mr. C Causes Major Interest in the Scientific Community
7. SuperGens PIM Kinase Inhibitor, SGI-1776, Causes Tumor Regression in AML Xenograft Models
8. SuperGen Identifies Lead PIM Kinase Inhibitor, SGI-1776, That Causes Tumor Regression in AML Xenograft Models
9. Mayo Clinic Study Identifies Potential Causes of Young-Onset Dementia
10. Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer
11. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017  Express Scripts (NASDAQ: ESRX ) was recognized ... Companies within the Health Care: Pharmacy and Other Services category. ... World,s Most Admired Companies," said Tim Wentworth , CEO and ... passion of our 26,000 employees to make medicine more affordable and ... ...
(Date:2/16/2017)...  Prescription pain medications provided by "physicians in the ... long-term opioid use to take hold," according to a ... of The New England Journal of Medicine ... in acute pain than in almost any other medical ... of the American College of Emergency Physicians. "The challenge ...
(Date:2/16/2017)... , Feb. 16, 2017   Spectralink ... solutions for the healthcare, retail, manufacturing and hospitality ... on the performance and symbology support features of ... a dual-mode camera/barcode scanner. The study, conducted by ... the PIVOT:SC to two phones with dedicated hardware ...
Breaking Medicine Technology:
(Date:2/19/2017)... ... February 19, 2017 , ... ... home healthcare, will join forces with Healthwise ® at HIMSS 2017 ... the industry leader in evidence-based health education, technology and services, will demonstrate a ...
(Date:2/18/2017)... ... , ... Park Cities Pet Sitter President, Joette White, has been featured on ... The episode, which was posted this week, features a 30-minute interview of White ... Cities Pet Sitter’s being awarded the 2017 National Association of Professional Pet Sitter’s Business ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... and sustainable systems change designed to further positively impact the health and wellness ... Trustees has long considered it our duty to seriously consider releasing our assets ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... Prevent a Warning Letter, **An FDAnews Webinar**, Feb. 23, 2017 — 1:30 p.m. ... distinguish between corrective action (CA) and preventive action (PA)? , The methods share ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... operations executives and focusing on all facets of clinical trial planning and management. ... , patient engagement, and more. In addition, attendees stopping by Pharmica’s booth were ...
Breaking Medicine News(10 mins):